Werewolf Therapeutics, Inc. (HOWL) vs Metagenomi, Inc. Common Stock (MGX)

A side-by-side comparison of Werewolf Therapeutics, Inc. and Metagenomi, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Werewolf Therapeutics, Inc. logo
HOWL
Werewolf Therapeutics, Inc.
$45M
$0.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Metagenomi, Inc. Common Stock logo
MGX
Metagenomi, Inc. Common Stock
$39M
$1.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — HOWL vs MGX

growth of $100 · dividends reinvested · last 3y
HOWL -86.5% (-48.8%/yr)MGX -89.9% (-53.4%/yr)HOWL compounded faster over this window
050100Start $10020252026$13$10
HOWL MGX

HOWL vs MGX: by the numbers

  • •HOWL is the larger company ($45M vs $39M market cap).
  • •Both run net losses; HOWL's is the smaller (-164.82% vs -689.20% net margin).

Metrics side by side

Valuation

MetricHOWLMGX
P/S ratio2.132.86
P/B ratio2.740.34

Profitability

MetricHOWLMGX
Gross margin0.00%74.29%
Operating margin0.00%-380.85%
Net margin-164.82%-689.20%
ROE-212.45%-83.03%
ROIC-156.97%-66.03%

Growth (annualized)

MetricHOWLMGX
Total return CAGR (5Y)-44.27%N/A

Go deeper

Full HOWL analysisFull MGX analysisInteractive comparison tool

Dig into the metrics

Werewolf Therapeutics ROEMetagenomi, Inc. Common Stock ROEWerewolf Therapeutics operating marginMetagenomi, Inc. Common Stock operating marginWerewolf Therapeutics revenue growthMetagenomi, Inc. Common Stock revenue growthWerewolf Therapeutics free cash flowMetagenomi, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.